Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for co…
The Targeting Online Sales of Fentanyl Act requires the Comptroller General (GAO) to conduct a study on the online sale of fentanyl, synthetic opioids, and methamphetamine and to report findings to Congress within one year of enactment. The study must examine business models and supply chains used by online sellers; the role of online illicit drug markets and providers (per 18 U.S.C. 2258E) in facilitating transactions, including impacts on persons under 18; federal, state, tribal, local, and foreign government efforts and interagency collaboration; provider detection technologies and enforcement practices; and referrals made by providers to the federal government, including counts and outcomes.
Progressives emphasize risks of surveillance, criminalization, and the need for public-health and civil-liberties safeguards; conservatives emphasize stronger enforcement and platform accountability.
Relative to its intended legislative type, this bill is a well-defined GAO study requirement: it clearly identifies topics to be examined and names the responsible entity with a one-year reporting deadline.
The Targeting Online Sales of Fentanyl Act requires the Comptroller General (GAO) to conduct a study on the online sale of fentanyl, synthetic opioids, and methamphetamine and to report findings to Congress within one year of enactment.
The study must examine business models and supply chains used by online sellers; the role of online illicit drug markets and providers (per 18 U.S.C. 2258E) in facilitating transactions, including impacts on persons under 18; federal, state, tribal, local, and foreign government efforts and interagency collaboration; provider detection technologies and enforcement practices; and referrals made by providers to the federal government, including counts and outcomes.
The GAO must analyze outcomes from the past ten years, identify coordination or resource gaps, and detail provider referrals that led to investigations, arrests, prosecutions, convictions, or sharing with subnational governments.
Because the bill only mandates a GAO study and report—an established, low-cost oversight mechanism—it is much more likely to clear congressional committees and floor consideration than major regulatory or spending legislation. The topic is high-salience but the investigatory form reduces ideological friction. Remaining barriers are procedural (scheduling, holds) and any objections about scope or duplication of existing studies.
Relative to its intended legislative type, this bill is a well-defined GAO study requirement: it clearly identifies topics to be examined and names the responsible entity with a one-year reporting deadline. It lacks only procedural and resourcing particulars that would help ensure comprehensiveness and timely execution given the breadth of the subjects to be studied.
Progressives emphasize risks of surveillance, criminalization, and the need for public-health and civil-liberties safeguards; conservatives emphasize stronger enforcement and platform accountability.
These are examples from the analysis, not a ranked list of the most-affected groups.
Progressives emphasize risks of surveillance, criminalization, and the need for public-health and civil-liberties safeguards; conservatives emphasize stronger enforcement and platform accountability.
A mainstream progressive would likely view the bill as a potentially useful fact-finding step to understand how illicit drugs are sold online, including risks to minors.
They would welcome the focus on platform detection technologies and provider referrals if the study yields data that can be used to expand public-health responses and prevention efforts.
However, they would be cautious that GAO findings could be used to justify expanded surveillance, criminalization, or enforcement-first policies rather than public-health, harm-reduction, and treatment responses.
A pragmatic moderate would generally support the bill as a reasonable, nonbinding fact-finding exercise to inform policy on a serious public-health and public-safety problem.
They would appreciate the GAO’s broad remit—looking at technology, interagency coordination, referrals, and outcomes—to identify practical gaps and improvements.
Their main concerns would be whether the study duplicates existing work, whether the one-year deadline is realistic given complexity, and that the study’s recommendations be followed by costed, implementable options rather than rhetoric.
A mainstream conservative would likely support the bill as a modest, evidence-building measure aimed at addressing the fentanyl and synthetic opioid crisis and improving platform accountability.
They would welcome analysis of referrals, prosecution outcomes, and interagency coordination as potential paths to strengthen law enforcement and disrupt supply chains.
They might be disappointed the bill does not itself mandate stronger enforcement actions, sanctions for non-cooperating platforms, or immediate resource increases, viewing this as a cautious first step.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Because the bill only mandates a GAO study and report—an established, low-cost oversight mechanism—it is much more likely to clear congressional committees and floor consideration than major regulatory or spending legislation. The topic is high-salience but the investigatory form reduces ideological friction. Remaining barriers are procedural (scheduling, holds) and any objections about scope or duplication of existing studies.
The bill has not accumulated any surfaced votes yet.
Progressives emphasize risks of surveillance, criminalization, and the need for public-health and civil-liberties safeguards; conservatives…
Because the bill only mandates a GAO study and report—an established, low-cost oversight mechanism—it is much more likely to clear congress…
Relative to its intended legislative type, this bill is a well-defined GAO study requirement: it clearly identifies topics to be examined and names the responsible entity with a one-year reporting deadline. It lacks onl…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.